Peficitinib inhibits fibroblast-like synoviocyte activation and angiogenic vascular endothelial tube formation via inhibitory effects on PDGF and VEGF signaling in addition to JAK
Purpose: Peficitinib and tofacitinib are known to suppress inflammation in rheumatoid arthritis (RA) by inhibiting Janus kinases (JAKs). However, these effects on tyrosine kinases other than JAKs have not yet been well investigated. We evaluated the effects of peficitinib and tofacitinib on platelet...
Guardat en:
| Autors principals: | , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Elsevier
2022-10-01
|
| Col·lecció: | Journal of Pharmacological Sciences |
| Matèries: | |
| Accés en línia: | http://www.sciencedirect.com/science/article/pii/S1347861322000524 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|